Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer (Faculty Presentations)

Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer (Faculty Presentations)

Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer (Faculty Presentations)

Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer (Faculty Presentations)

Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer (Faculty Presentations)

Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer
(Faculty Presentations)

Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer (Faculty Presentations)

Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer (Faculty Presentations)

Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Faculty Presentations)

Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Faculty Presentations)

Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Faculty Presentations)

Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Faculty Presentations)

2023 Webinar Archive | MTP Melanoma

Webinar Archive

Please note: This archive is for informational purposes only. CME credit is only available to those who attended the live event.

Inside the Issue: Optimizing the Management of Metastatic Pancreatic Cancer (Faculty Presentations)

Inside the Issue: Optimizing the Management of Metastatic Pancreatic Cancer (Faculty Presentations)

Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma (Faculty Presentations)

Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma (Faculty Presentations)

Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer (Faculty Presentation)

Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer (Faculty Presentation)

Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer (Faculty Presentation)

Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor (Faculty Presentations)

Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor (Faculty Presentations)

Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor (Faculty Presentations)

Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management (Faculty Presentations)

Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management (Faculty Presentations)

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Oncology — Melanoma and Nonmelanoma Skin Cancers (Faculty Presentations)

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Oncology — Melanoma and Nonmelanoma Skin Cancers (Faculty Presentations)

Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes (Faculty Presentations)

Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes (Faculty Presentations)

Syndicate content